Inheritor Cell Technology

As a forthcoming biomedical clinic, Inheritor Cell Technology, Inc. accentuates its focus on stem cell research and clinical applications. We are committed to the development of stem cell preparation, application treatment and pharmaceuticals, with an emphasis on human health services such as disease research, genetic testing, assisted reproduction, organ regeneration, genetic science, and many more through human-derived biological sample banks. Dr. An is our Chief Medical Officer of ICT U.S. who is also the world’s most renewed stem cell therapist with tens of thousands of clinical treatment cases followed by twenty-six National Institutes of Health (NIH) and Food and Drug Administration (FDA) clinical trial registrations, both of which have successfully passed Phase III clinical trials. During this rapid growth of Artificial Intelligence (AI), we are profoundly aware that our future will not only lead to the development of smarter machines, but also making humans healthier.